Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) Latest Advances

Outpatient versus inpatient initiation of home mechanical ventilation in patients with amyotrophic lateral sclerosis - a protocol for a randomised trial.

Journal: Danish medical journal

Published: April 14, 2026

Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: April 13, 2026

Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening.

Journal: Autophagy

Published: April 13, 2026

Primary lateral sclerosis in Brazil: phenotypic heterogeneity, non-motor features, and prognostic markers in a 17-year multicentre cohort.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: April 13, 2026

Fast and controlled access to tofersen for SOD1-related amyotrophic lateral sclerosis in The Netherlands; experiences using the orphan drug access protocol.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: April 13, 2026

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasis.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Longitudinal Analysis of Superoxide Dismutase 1 Seeding Activity in Amyotrophic Lateral Sclerosis Cerebrospinal Fluid.

Journal: medRxiv : the preprint server for health sciences

Published: April 03, 2026

Stable speech BCI performance during slow progression of ALS: A longitudinal ECoG study.

Journal: Research square

Published: April 03, 2026

Long-Term Exposure to Ambient Air Pollution and Incident Amyotrophic Lateral Sclerosis: A Prospective Cohort Analysis of the UK Biobank.

Journal: Neurology

Published: April 03, 2026

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

From theory to practice: physicians' knowledge, attitudes, and practices regarding amyotrophic lateral sclerosis in Egypt - a cross-sectional study.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: April 03, 2026

Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease) Latest Advances

Find the Latest Research About Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)

Outpatient versus inpatient initiation of home mechanical ventilation in patients with amyotrophic lateral sclerosis - a protocol for a randomised trial.

Outpatient versus inpatient initiation of home mechanical ventilation in patients with amyotrophic lateral sclerosis - a protocol for a randomised trial.

Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population.

Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population.

Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening.

Discovery of a novel TFEB activator targeting lysosomal dysfunction in amyotrophic lateral sclerosis using artificial intelligence-based virtual screening.

Primary lateral sclerosis in Brazil: phenotypic heterogeneity, non-motor features, and prognostic markers in a 17-year multicentre cohort.

Primary lateral sclerosis in Brazil: phenotypic heterogeneity, non-motor features, and prognostic markers in a 17-year multicentre cohort.

Fast and controlled access to tofersen for SOD1-related amyotrophic lateral sclerosis in The Netherlands; experiences using the orphan drug access protocol.

Fast and controlled access to tofersen for SOD1-related amyotrophic lateral sclerosis in The Netherlands; experiences using the orphan drug access protocol.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Cross-disease genetic and epigenetic architecture of the MOBP locus shows convergence in ALS-PSP.

Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasis.

Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasis.

Longitudinal Analysis of Superoxide Dismutase 1 Seeding Activity in Amyotrophic Lateral Sclerosis Cerebrospinal Fluid.

Longitudinal Analysis of Superoxide Dismutase 1 Seeding Activity in Amyotrophic Lateral Sclerosis Cerebrospinal Fluid.

Stable speech BCI performance during slow progression of ALS: A longitudinal ECoG study.

Stable speech BCI performance during slow progression of ALS: A longitudinal ECoG study.

Long-Term Exposure to Ambient Air Pollution and Incident Amyotrophic Lateral Sclerosis: A Prospective Cohort Analysis of the UK Biobank.

Long-Term Exposure to Ambient Air Pollution and Incident Amyotrophic Lateral Sclerosis: A Prospective Cohort Analysis of the UK Biobank.

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

Multimodal analysis of cell-free DNA identifies epigenetic biomarkers for amyotrophic lateral sclerosis diagnosis and progression.

From theory to practice: physicians' knowledge, attitudes, and practices regarding amyotrophic lateral sclerosis in Egypt - a cross-sectional study.

From theory to practice: physicians' knowledge, attitudes, and practices regarding amyotrophic lateral sclerosis in Egypt - a cross-sectional study.